Major Neurocognitive Disorder (NCD), commonly associated with conditions like Alzheimer's disease and other forms of dementia, is characterized by significant decline in cognitive abilities such as memory, reasoning, and judgment. Alzheimer's disease, the most prevalent cause of NCD, involves progressive neurodegeneration and the formation of amyloid plaques and neurofibrillary tangles in the brain, leading to memory loss, disorientation, and behavioral changes.
Dementia, a broader category of NCD, encompasses various conditions that impair cognitive function enough to interfere with daily life. It affects millions worldwide, impacting not only individuals but also their families and caregivers. Early diagnosis and intervention are crucial for managing symptoms and planning care. Research continues to explore treatments to alleviate symptoms and slow progression, highlighting the urgent need for more effective therapies and support systems for those affected by these challenging conditions.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States